Press releaseBusiness Wire
Marpai
MRAI · OTC
$3.17−$0.014 (−0.44%)TodayMarket closed ·
Prev close $3.18
Latest news
- Press releasePRNewswire
Marpai Reports Second Quarter 2026 Financial Results
- Press releasePRNewswire
Marpai Announces $12 Million Private Placement led by Mitchell Companies
- Press releasePRNewswire
Marpai Inc. Announces Debt Restructuring Agreements with JGB Capital and AXA, Reducing Debt Service by $26.4 Million Through 2027 and Enhances Near term Liquidity
- Press releasePRNewswire
Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026
- Press releasePRNewswire
MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
- Press releasePRNewswire
Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability
- Press releasePRNewswire
Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide
- Press releasePRNewswire
Marpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered Lives
- Press releasePRNewswire
Marpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform Expansion
- Press releasePRNewswire
MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH
- Press releasePRNewswire
MARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSION
- Press releasePRNewswire
MARPAI REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
- Press releasePRNewswire
MARPAI TO HOST WEBCAST ON NOVEMBER 13, 2025 TO DISCUSS THIRD QUARTER 2025 FINANCIAL RESULTS
- Press releasePRNewswire
MARPAI RECOGNIZED AS 2025 TOP THIRD PARTY ADMINISTRATOR
- Press releasePRNewswire
MARPAI, INC. RECEIVES ADDITIONAL $200,000 INVESTMENT FROM DAMIEN LAMENDOLA'S HILLCOUR INVESTMENT FUND
- Press releasePRNewswire
MARPAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
- Press releasePRNewswire
MARPAI TO HOST WEBCAST ON AUGUST 14, 2025 TO DISCUSS SECOND QUARTER 2025 FINANCIAL RESULTS
- Press releasePRNewswire
MARPAIRX REVOLUTIONIZES PHARMACY BENEFITS WITH UNPRECEDENTED TRANSPARENCY AND SAVINGS
- Press releasePRNewswire
MARPAI REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
- Press releasePRNewswire
MARPAI HIRES DALLAS SCRIP AS CHIEF OPERATING OFFICER
- Press releasePRNewswire
MARPAI TO HOST WEBCAST ON MAY 15, 2025 TO DISCUSS FIRST QUARTER 2025 FINANCIAL RESULTS
- Press releasePRNewswire
Marpai, Inc. to Present at the Planet MicroCap Showcase Las Vegas
- Press releasePRNewswire
MARPAI REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
- Press releasePRNewswire
MARPAI TO HOST WEBCAST ON MARCH 27, 2025 TO DISCUSS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
- Press releasePRNewswire
MARPAI ACCELERATES HEALTHCARE TRANSFORMATION WITH EMPARA COLLABORATION, LAUNCHING UNIFIED HEALTH ENGAGEMENT PLATFORM
- Press releasePRNewswire
MARPAI REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
- Press releasePRNewswire
MARPAI REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.